Valbenazine (Ingrezza): The First FDA-Approved Treatment for Tardive Dyskinesia. [electronic resource]

By: Contributor(s): Publication details: P & T : a peer-reviewed journal for formulary management Jun 2018Description: 328-331 p. digitalISSN:
  • 1052-1372
 In: P & T : a peer-reviewed journal for formulary management vol. 43
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.
Previous
Back to results
Next
Close